detalle del documento
IDENTIFICACIÓN

oai:pubmedcentral.nih.gov:1063...

Tema
Article
Autor
Soos, Brandy-Lee Ballinger, Alec Weinstein, Mykayla Foreman, Haley Grampone, Julianna Weafer, Samuel Aylesworth, Connor King, Benjamin L.
Langue
en
Editor

Cold Spring Harbor Laboratory

Categoría

biorxiv

Año

2023

fecha de cotización

15/11/2023

Palabras clave
influenza innate immune zebrafish infection model
Métrico

Resumen

Influenza virus infection can cause severe respiratory disease and is estimated to cause millions of illnesses annually.

Studies of the contribution of the innate immune response to influenza A virus (IAV) to viral pathogenesis may yield new antiviral strategies.

Zebrafish larvae are useful models to study the innate immune response to pathogens, including IAV, in vivo .

Here, we demonstrate how Color-flu, four fluorescent IAV strains originally developed for mice, can be used to study host-virus interactions by simultaneously monitoring virus particles, neutrophils, and macrophages in vivo .

Using this model, we show how the angiotensin-converting enzyme inhibitor, ramipril, and mitophagy inhibitor, MDIVI-1, improved survival, decreased viral burden, and improved the respiratory burst response to IAV infection.

The Color-flu zebrafish model of IAV infection is complementary to other models as it is the only model where interactions between virus particles and host cells in an intact vertebrate can be visualized in vivo .

Soos, Brandy-Lee,Ballinger, Alec,Weinstein, Mykayla,Foreman, Haley,Grampone, Julianna,Weafer, Samuel,Aylesworth, Connor,King, Benjamin L., 2023, Multi-spectral Fluorescent Reporter Influenza A Viruses Allow for in vivo Studies of Innate Immune Function in Zebrafish , Cold Spring Harbor Laboratory

Compartir

Fuente

Artículos recomendados por ES/IODE IA

Acceptability of self-collected vaginal samples for human papillomavirus testing for primary cervical cancer screening: comparison of face-to-face and online recruitment modes
human papillomavirus cervical cancer screening self-sampling screening cervical cancer 1% uptake rate website acceptability online face-to-face participants